LOADING...
   BC013200;WT2001B
Protein Sequence Comparative Analysis   (PSCA)
 
  Back to Target List
 

BC013200    REFERENCE SYSTEM

Accession: BC013200
Description: BC013200 Homo sapiens lymphocyte-specific protein tyrosine kinase, mRNA (cDNA clone MGC:17196 IMAGE:4341278), complete cds, coding region:101-1720
Organism: HOMO SAPIENS
Keyword: BC013200 Homo sapiens lymphocyte-specific protein tyrosine kinase, mRNA (cDNA clone MGC:17196 IMAGE:4341278), complete cds, coding region:101-1720

  

References           
PMID Filter
     Deleting genome references          
     Reference classification      Trusted or extreme similarity       Gathering or high similarity       Noise or low similarity
 
Sequence reference                    
   SP-EMBL: ;  PMID:;
   GenBank: ;  PMID:;
Family annotation                  
1.          trusted          evalue:0.0e+00
    Pfam:PF07714   Protein tyrosine kinase;  PMID:;
2.          trusted          evalue:2.4e-49
    Pfam:v3_1_0:1p4oA02   0;  PMID:;
3.          trusted          evalue:1.7e-51
    Pfam:v3_1_0:1opjA02   0;  PMID:;
4.          trusted          evalue:9.3e-55
    Pfam:v3_1_0:1xbbA02   0;  PMID:;
5.          trusted          evalue:4.9e-49
    Pfam:v3_1_0:1t46A02   0;  PMID:;
6.          trusted          evalue:2.5e-48
    Pfam:v3_1_0:1rdqE01   0;  PMID:;
7.          trusted          evalue:1.8e-47
    Pfam:v3_1_0:1kwpB02   0;  PMID:;
8.          trusted          evalue:7.0e-48
    Pfam:v3_1_0:1s9jA02   0;  PMID:;
9.          trusted          evalue:2.4e-51
    Pfam:v3_1_0:2src004   0;  PMID:;
10.          trusted          evalue:1.9e-47
    Pfam:v3_1_0:1s9iA02   0;  PMID:;
11.          trusted          evalue:8.3e-49
    Pfam:v3_1_0:1tkiA02   0;  PMID:;
12.          trusted          evalue:7.1e-46
    Pfam:v3_1_0:1vjyA02   0;  PMID:;
13.          trusted          evalue:3.1e-44
    Pfam:PF00017   SH2 domain;  PMID:;
14.          trusted          evalue:2.5e-44
    Pfam:v3_1_0:1q3dA02   0;  PMID:;
15.          trusted          evalue:3.6e-45
    Pfam:v3_1_0:1uwhA02   0;  PMID:;
16.          trusted          evalue:4.1e-48
    Pfam:v3_1_0:1o6yA02   0;  PMID:;
17.          trusted          evalue:9.5e-49
    Pfam:v3_1_0:1gz8A02   0;  PMID:;
18.          trusted          evalue:4.1e-46
    Pfam:v3_1_0:1o6lA01   0;  PMID:;
19.          trusted          evalue:4.5e-45
    Pfam:v3_1_0:2j0iA02   0;  PMID:;
20.          trusted          evalue:2.5e-46
    Pfam:v3_1_0:1kobA02   0;  PMID:;
21.          trusted          evalue:1.2e-44
    Pfam:v3_1_0:2izrA02   0;  PMID:;
22.          trusted          evalue:1.2e-52
    Pfam:v3_1_0:2i6lA02   0;  PMID:;
23.          trusted          evalue:1.2e-49
    Pfam:v3_1_0:1jksA02   0;  PMID:;
24.          trusted          evalue:7.6e-46
    Pfam:v3_1_0:2bfyA02   0;  PMID:;
25.          trusted          evalue:1.0e-43
    Pfam:v3_1_0:1ia8A02   0;  PMID:;
26.          trusted          evalue:3.8e-50
    Pfam:v3_1_0:1wbsA02   0;  PMID:;
27.          trusted          evalue:7.1e-42
    Pfam:v3_1_0:1xwsA02   0;  PMID:;
28.          trusted          evalue:7.6e-41
    Pfam:v3_1_0:1ymiA01   0;  PMID:;
29.          trusted          evalue:1.2e-42
    Pfam:v3_1_0:1wakA02   0;  PMID:;
30.          trusted          evalue:6.5e-38
    Pfam:PF00069   Protein kinase domain;  PMID:1956325,7768349,9020587;
31.          trusted          evalue:9.9e-41
    Pfam:v3_1_0:1t4hA02   0;  PMID:;
32.          trusted          evalue:4.0e-35
    Pfam:v3_1_0:1uurA04   0;  PMID:;
33.          trusted          evalue:1.9e-37
    Pfam:v3_1_0:1lkkA00   0;  PMID:;
34.          trusted          evalue:8.6e-33
    Pfam:v3_1_0:2huyA00   0;  PMID:;
35.          trusted          evalue:1.9e-32
    Pfam:v3_1_0:1a81E01   0;  PMID:;
36.          trusted          evalue:3.4e-31
    Pfam:v3_1_0:1luiA00   0;  PMID:;
37.          trusted          evalue:6.5e-31
    Pfam:v3_1_0:2iugA00   0;  PMID:;
38.          trusted          evalue:5.8e-32
    Pfam:v3_1_0:1nrvA00   0;  PMID:;
39.          trusted          evalue:1.8e-28
    Pfam:v3_1_0:2shpA02   0;  PMID:;
40.          trusted          evalue:2.2e-28
    Pfam:v3_1_0:1mil000   0;  PMID:;
41.          trusted          evalue:7.0e-30
    Pfam:v3_1_0:1qadA00   0;  PMID:;
42.          trusted          evalue:5.8e-31
    Pfam:v3_1_0:1opkA02   0;  PMID:;
43.          trusted          evalue:4.4e-29
    Pfam:v3_1_0:1xa6A01   0;  PMID:;
44.          trusted          evalue:3.0e-30
    Pfam:v3_1_0:1d4tA00   0;  PMID:;
45.          trusted          evalue:1.3e-27
    Pfam:v3_1_0:1ayaA00   0;  PMID:;
46.          trusted          evalue:1.4e-29
    Pfam:v3_1_0:1r1pB00   0;  PMID:;
47.          trusted          evalue:1.5e-26
    Pfam:v3_1_0:1ju5A00   0;  PMID:;
48.          trusted          evalue:6.9e-28
    Pfam:v3_1_0:1jwoA00   0;  PMID:;
49.          trusted          evalue:1.6e-26
    Pfam:v3_1_0:1rpyB00   0;  PMID:;
50.          trusted          evalue:1.2e-25
    Pfam:v3_1_0:2pldA00   0;  PMID:;
51.          trusted          evalue:9.4e-26
    Pfam:v3_1_0:1b6cB01   0;  PMID:;
52.          trusted          evalue:1.2e-22
    Pfam:v3_1_0:1fmk003   0;  PMID:;
53.          trusted          evalue:6.6e-23
    Pfam:v3_1_0:1rjbA01   0;  PMID:;
54.          trusted          evalue:1.8e-20
    Pfam:v3_1_0:1tvoA01   0;  PMID:;
55.          trusted          evalue:1.0e-19
    Pfam:PF00018   SH3 domain;  PMID:12169629;
56.          trusted          evalue:4.9e-21
    Pfam:v3_1_0:1u4dA01   0;  PMID:;
57.          trusted          evalue:1.3e-19
    Pfam:v3_1_0:1opjB01   0;  PMID:;
58.          trusted          evalue:5.4e-21
    Pfam:v3_1_0:1p4oA01   0;  PMID:;
59.          trusted          evalue:2.5e-20
    Pfam:v3_1_0:1mp8A01   0;  PMID:;
60.          trusted          evalue:3.8e-20
    Pfam:v3_1_0:1o6lA02   0;  PMID:;
61.          trusted          evalue:1.3e-20
    Pfam:v3_1_0:2fb8A01   0;  PMID:;
62.          trusted          evalue:4.1e-20
    Pfam:v3_1_0:1xbbA01   0;  PMID:;
63.          trusted          evalue:4.3e-21
    Pfam:v3_1_0:1vjyA01   0;  PMID:;
64.          trusted          evalue:5.9e-20
    Pfam:v3_1_0:1r1wA01   0;  PMID:;
65.          trusted          evalue:2.8e-19
    Pfam:v3_1_0:1t46A01   0;  PMID:;
66.          trusted          evalue:4.3e-18
    Pfam:v3_1_0:1n5zB00   0;  PMID:;
67.          trusted          evalue:8.0e-21
    Pfam:v3_1_0:1jegA00   0;  PMID:;
68.          trusted          evalue:3.4e-19
    Pfam:v3_1_0:1m14A01   0;  PMID:;
69.          trusted          evalue:1.0e-18
    Pfam:v3_1_0:1uffA00   0;  PMID:;
70.          trusted          evalue:1.2e-17
    Pfam:v3_1_0:1lufA01   0;  PMID:;
71.          trusted          evalue:1.0e-16
    Pfam:v3_1_0:1fvrA01   0;  PMID:;
72.          trusted          evalue:4.4e-17
    Pfam:v3_1_0:1jxmA01   0;  PMID:;
73.          trusted          evalue:1.8e-17
    Pfam:v3_1_0:1udlA00   0;  PMID:;
74.          trusted          evalue:3.2e-17
    Pfam:v3_1_0:1t0hA00   0;  PMID:;
75.          trusted          evalue:1.3e-16
    Pfam:v3_1_0:1q5kA01   0;  PMID:;
76.          trusted          evalue:5.6e-16
    Pfam:v3_1_0:1kobA01   0;  PMID:;
77.          trusted          evalue:1.6e-15
    Pfam:v3_1_0:1uhfA00   0;  PMID:;
78.          trusted          evalue:9.0e-16
    Pfam:v3_1_0:1ywrA01   0;  PMID:;
79.          trusted          evalue:5.9e-15
    Pfam:v3_1_0:1awj000   0;  PMID:;
80.          trusted          evalue:1.4e-14
    Pfam:v3_1_0:1ad5A01   0;  PMID:;
81.          trusted          evalue:2.7e-15
    Pfam:v3_1_0:1pht000   0;  PMID:;
82.          trusted          evalue:6.5e-16
    Pfam:v3_1_0:2i6lA01   0;  PMID:;
83.          trusted          evalue:9.2e-15
    Pfam:v3_1_0:1qcfA01   0;  PMID:;
84.          trusted          evalue:1.5e-15
    Pfam:v3_1_0:1t4hB01   0;  PMID:;
85.          trusted          evalue:8.2e-15
    Pfam:v3_1_0:2bfyA01   0;  PMID:;
86.          trusted          evalue:8.6e-15
    Pfam:v3_1_0:2j0iA01   0;  PMID:;
87.          trusted          evalue:2.3e-15
    Pfam:v3_1_0:1blxA01   0;  PMID:;
88.          trusted          evalue:4.9e-14
    Pfam:v3_1_0:1aww000   0;  PMID:;
89.          trusted          evalue:6.2e-15
    Pfam:v3_1_0:1ia8A01   0;  PMID:;
90.          trusted          evalue:8.8e-15
    Pfam:v3_1_0:1pme001   0;  PMID:;
91.          trusted          evalue:7.2e-14
    Pfam:v3_1_0:1opkA01   0;  PMID:;
92.          trusted          evalue:6.3e-14
    Pfam:v3_1_0:1gcqC00   0;  PMID:;
93.          trusted          evalue:9.4e-14
    Pfam:v3_1_0:1gz8A01   0;  PMID:;
94.          trusted          evalue:7.8e-14
    Pfam:v3_1_0:1a06001   0;  PMID:;
95.          trusted          evalue:3.6e-14
    Pfam:v3_1_0:1wbsA01   0;  PMID:;
96.          trusted          evalue:1.9e-13
    Pfam:v3_1_0:1jksA01   0;  PMID:;
97.          trusted          evalue:3.5e-13
    Pfam:v3_1_0:1yhvA01   0;  PMID:;
98.          trusted          evalue:1.1e-12
    Pfam:v3_1_0:1ng2A02   0;  PMID:;
99.          trusted          evalue:1.5e-13
    Pfam:v3_1_0:1xwsA01   0;  PMID:;
100.          trusted          evalue:8.7e-13
    Pfam:v3_1_0:1wx6A01   0;  PMID:;
101.          trusted          evalue:4.5e-14
    Pfam:v3_1_0:1wakA01   0;  PMID:;
102.          trusted          evalue:4.9e-13
    Pfam:v3_1_0:1tkiA01   0;  PMID:;
103.          trusted          evalue:2.5e-12
    Pfam:v3_1_0:1bb9000   0;  PMID:;
104.          trusted          evalue:5.6e-13
    Pfam:v3_1_0:1spkA00   0;  PMID:;
105.          trusted          evalue:3.4e-13
    Pfam:v3_1_0:1jo8A00   0;  PMID:;
106.          trusted          evalue:3.1e-12
    Pfam:v3_1_0:1i07A00   0;  PMID:;
107.          trusted          evalue:1.8e-12
    Pfam:v3_1_0:1s9jA01   0;  PMID:;
108.          trusted          evalue:7.1e-12
    Pfam:v3_1_0:1ycsB02   0;  PMID:;
109.          trusted          evalue:1.6e-12
    Pfam:v3_1_0:1x6bA01   0;  PMID:;
110.          trusted          evalue:1.1e-11
    Pfam:v3_1_0:1pwt000   0;  PMID:;
111.          trusted          evalue:8.0e-15
    Pfam:v3_1_0:1vytA01   0;  PMID:;
112.          trusted          evalue:1.3e-11
    Pfam:v3_1_0:1nm7A00   0;  PMID:;
113.          trusted          evalue:5.8e-10
    Pfam:PF07653   Variant SH3 domain;  PMID:;
114.          trusted          evalue:3.3e-12
    Pfam:v3_1_0:1tuc000   0;  PMID:;
115.          trusted          evalue:1.2e-11
    Pfam:v3_1_0:1ug1A00   0;  PMID:;
116.          trusted          evalue:2.1e-12
    Pfam:v3_1_0:1o6yA01   0;  PMID:;
117.          trusted          evalue:9.5e-13
    Pfam:v3_1_0:1ov3A02   0;  PMID:;
118.          trusted          evalue:1.5e-12
    Pfam:v3_1_0:1y0mA00   0;  PMID:;
119.          trusted          evalue:2.6e-11
    Pfam:v3_1_0:1griA01   0;  PMID:;
120.          trusted          evalue:2.0e-12
    Pfam:v3_1_0:1ark000   0;  PMID:;
121.          trusted          evalue:3.6e-11
    Pfam:v3_1_0:1sshA00   0;  PMID:;
122.          trusted          evalue:1.0e-11
    Pfam:v3_1_0:1i1jB00   0;  PMID:;
123.          trusted          evalue:6.2e-11
    Pfam:v3_1_0:1zx6A00   0;  PMID:;
124.          trusted          evalue:9.3e-11
    Pfam:v3_1_0:1ckaA00   0;  PMID:;
125.          trusted          evalue:5.7e-11
    Pfam:v3_1_0:1rdqE02   0;  PMID:;
126.          trusted          evalue:1.5e-11
    Pfam:v3_1_0:1uu3A02   0;  PMID:;
127.          trusted          evalue:7.4e-12
    Pfam:v3_1_0:1w70A00   0;  PMID:;
128.          trusted          evalue:9.1e-12
    Pfam:v3_1_0:1ymiA02   0;  PMID:;
129.          trusted          evalue:2.5e-10
    Pfam:v3_1_0:2csqA01   0;  PMID:;
130.          trusted          evalue:4.3e-11
    Pfam:v3_1_0:1phk001   0;  PMID:;
131.          trusted          evalue:1.5e-10
    Pfam:v3_1_0:1ov3A01   0;  PMID:;
132.          trusted          evalue:6.0e-10
    Pfam:v3_1_0:1zlmA00   0;  PMID:;
133.          trusted          evalue:3.9e-09
    Pfam:v3_1_0:1zrzA01   0;  PMID:;
134.          trusted          evalue:7.8e-10
    Pfam:v3_1_0:1nxkA01   0;  PMID:;
135.          trusted          evalue:8.4e-10
    Pfam:v3_1_0:2izrA01   0;  PMID:;
136.          trusted          evalue:2.8e-09
    Pfam:v3_1_0:1ri9A00   0;  PMID:;
137.          trusted          evalue:2.7e-07
    Pfam:v3_1_0:1g2bA00   0;  PMID:;
138.          trusted          evalue:3.1e-07
    Pfam:v3_1_0:1ng2A01   0;  PMID:;
139.          trusted          evalue:1.8e-04
    Pfam:v3_1_0:1ckiA01   0;  PMID:;
 
PDB similairty                    
No.    Start    End    Identity%    Coverage%    Evalue
1.          225          531          90          56.77          0.0e+00
     Pdb:3BYU CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE REVERSE AMID; PMID:;
     Pdb:3BYS CO-CRYSTAL STRUCTURE OF LCK AND AMINOPYRIMIDINE AMIDE 10B ; PMID:;
2.          225          539          90          58.26          0.0e+00
     Pdb:2PL0 LCK BOUND TO IMATINIB ; PMID:;
3.          225          539          90          58.26          0.0e+00
     Pdb:3AC5 CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO; PMID:;
     Pdb:3AC3 CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO; PMID:;
     Pdb:3ACJ CRYSTAL STRUCTURE OF IMIDAZO PYRIMIDINE DERIVATIVE BOUND TO ; PMID:;
     Pdb:2ZM1 CRYSTAL STRUCTURE OF IMIDAZO PYRAZIN 1 BOUND TO THE KINASE D; PMID:;
     Pdb:3AC1 CRYSTAL STRUCTURE OF PYRAZIN DERIVATIVE BOUND TO THE KINASE ; PMID:;
     Pdb:3AC2 CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO; PMID:;
     Pdb:3AD5 CRYSTAL STRUCTURE OF TRIAZOLONE DERIVATIVE BOUND TO THE KINA; PMID:;
     Pdb:2ZM4 CRYSTAL STRUCTURE OF IMIDAZO QUINOXALINE 1 BOUND TO THE KINA; PMID:;
     Pdb:3AC4 CRYSTAL STRUCTURE OF TRIAZOLO PYRIMIDINE DERIVATIVE BOUND TO; PMID:;
     Pdb:3AD6 CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO; PMID:;
     Pdb:3AC8 CRYSTAL STRUCTURE OF PYRAZOLO PYRIMIDINE DERIVATIVE BOUND TO; PMID:;
     Pdb:3AD4 CRYSTAL STRUCTURE OF METHOXY BENZOFURAN DERIVATIVE BOUND TO ; PMID:;
     Pdb:2ZYB CRYSTAL STRUCTURE OF PHENYLIMIDAZO PYRAZIN 2 BOUND TO THE KI; PMID:;
     Pdb:3ACK CRYSTAL STRUCTURE OF PYRROLO PYRAZINE DERIVATIVE BOUND TO TH; PMID:;
4.          225          539          90          58.26          0.0e+00
     Pdb:3KXZ THE COMPLEX CRYSTAL STRUCTURE OF LCK WITH A PROBE MOLECULE W; PMID:;
5.          226          532          90          56.77          0.0e+00
     Pdb:3B2W CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK ; PMID:;
     Pdb:2OFV CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK ; PMID:;
6.          229          531          90          56.03          0.0e+00
     Pdb:2OFU X-RAY CRYSTAL STRUCTURE OF 2-AMINOPYRIMIDINE CARBAMATE 43 BO; PMID:;
7.          229          539          90          57.51          0.0e+00
     Pdb:3KMM STRUCTURE OF HUMAN LCK KINASE WITH A SMALL MOLECULE INHIBITO; PMID:;
8.          230          531          90          55.84          0.0e+00
     Pdb:3BYM X-RAY CO-CRYSTAL STRUCTURE AMINOBENZIMIDAZOLE TRIAZINE 1 BOU; PMID:;
9.          231          531          90          55.66          0.0e+00
     Pdb:2OF2 CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 8 BOUND TO LCK ; PMID:;
     Pdb:3LCK THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATE; PMID:8945479;
     Pdb:2OF4 CRYSTAL STRUCTURE OF FURANOPYRIMIDINE 1 BOUND TO LCK ; PMID:;
     Pdb:3BYO X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5', 4; PMID:18278858;
10.          231          539          90          57.14          0.0e+00
     Pdb:1QPC STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN; PMID:10404594;
     Pdb:1QPE STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN; PMID:10404594;
     Pdb:1QPJ CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN C; PMID:;
11.          231          539          89          57.14          0.0e+00
     Pdb:1QPD STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN; PMID:10404594;
12.          236          530          89          54.55          0.0e+00
     Pdb:2OG8 CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 36 BOUND TO LCK ; PMID:;
13.          237          531          89          54.55          0.0e+00
     Pdb:3MPM LCK COMPLEXED WITH A PYRAZOLOPYRIMIDINE ; PMID:;
14.          65          539          67          87.94          0.0e+00
     Pdb:3VRZ CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:2C0O SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041 ; PMID:;
     Pdb:4LUE CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH 7-[TRANS-4-(4- METH; PMID:;
     Pdb:1QCF CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY- SELEC; PMID:10360180;
     Pdb:2C0I SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983 ; PMID:;
     Pdb:3VS5 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:3VS7 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDIN; PMID:;
     Pdb:3VS6 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRAZOLO-PYRIMIDIN; PMID:;
     Pdb:2C0T SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359 ; PMID:;
     Pdb:3VRY CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:3VS0 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:3VS2 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:3VS3 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:3VS4 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
     Pdb:4LUD CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH THE FLUORESCENT COM; PMID:;
     Pdb:3VS1 CRYSTAL STRUCTURE OF HCK COMPLEXED WITH A PYRROLO-PYRIMIDINE; PMID:;
15.          62          539          65          88.50          0.0e+00
     Pdb:1AD5 SRC FAMILY KINASE HCK-AMP-PNP COMPLEX ; PMID:9024658;
     Pdb:2HCK SRC FAMILY KINASE HCK-QUERCETIN COMPLEX ; PMID:9024658;
16.          67          537          57          87.20          0.0e+00
     Pdb:2PTK CHICKEN SRC TYROSINE KINASE ; PMID:9405157,9108021;
17.          58          537          56          88.87          0.0e+00
     Pdb:2H8H SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR ; PMID:;
18.          67          537          56          87.20          0.0e+00
     Pdb:1FMK CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC ; PMID:9024657;
     Pdb:1Y57 STRUCTURE OF UNPHOSPHORYLATED C-SRC IN COMPLEX WITH AN INHIB; PMID:;
     Pdb:2SRC CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN; PMID:10360179;
19.          67          537          56          87.20          0.0e+00
     Pdb:1KSW STRUCTURE OF HUMAN C-SRC TYROSINE KINASE (THR338GLY MUTANT) ; PMID:11841936;
20.          67          537          56          87.20          0.0e+00
     Pdb:4K11 THE STRUCTURE OF 1NA IN COMPLEX WITH SRC T338G ; PMID:;
21.          231          539          67          57.14          1.0e-120
     Pdb:3A4O LYN KINASE DOMAIN ; PMID:;
22.          230          527          69          55.10          1.0e-118
     Pdb:2HK5 HCK KINASE IN COMPLEX WITH LCK TARGETTED INHIBITOR PG-100924; PMID:;
23.          238          539          66          55.84          1.0e-116
     Pdb:2ZV9 LYN TYROSINE KINASE DOMAIN-PP2 COMPLEX ; PMID:;
     Pdb:2ZV7 LYN TYROSINE KINASE DOMAIN, APO FORM ; PMID:;
     Pdb:2ZV8 LYN TYROSINE KINASE DOMAIN-AMP-PNP COMPLEX ; PMID:;
     Pdb:2ZVA LYN TYROSINE KINASE DOMAIN-DASATINIB COMPLEX ; PMID:;
24.          235          537          63          56.03          1.0e-108
     Pdb:2DQ7 CRYSTAL STRUCTURE OF FYN KINASE DOMAIN COMPLEXED WITH STAURO; PMID:;
25.          235          537          61          56.03          1.0e-106
     Pdb:2BDF SRC KINASE IN COMPLEX WITH INHIBITOR AP23451 ; PMID:;
     Pdb:2BDJ SRC KINASE IN COMPLEX WITH INHIBITOR AP23464 ; PMID:;
26.          235          537          61          56.03          1.0e-106
     Pdb:4MXO HUMAN SRC KINASE BOUND TO KINASE INHIBITOR BOSUTINIB ; PMID:;
27.          236          537          61          55.84          1.0e-106
     Pdb:1YI6 C-TERM TAIL SEGMENT OF HUMAN TYROSINE KINASE (258-533) ; PMID:;
28.          235          537          60          56.03          1.0e-106
     Pdb:1YOL CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH CGP77; PMID:;
29.          235          537          61          56.03          1.0e-105
     Pdb:3EN4 TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KI; PMID:;
     Pdb:3EN5 TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KI; PMID:;
     Pdb:3D7T STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIV; PMID:;
     Pdb:3F6X C-SRC KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE INHIBITOR; PMID:;
     Pdb:3UQG C-SRC KINASE DOMAIN IN COMPLEX WITH BUMPLESS BKI ANALOG UW12; PMID:;
     Pdb:4U5J C-SRC IN COMPLEX WITH RUXOLITINIB ; PMID:;
     Pdb:2OIQ CRYSTAL STRUCTURE OF CHICKEN C-SRC KINASE DOMAIN IN COMPLEX ; PMID:;
     Pdb:3EN6 TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KI; PMID:;
     Pdb:3DQX CHICKEN C-SRC KINASE DOMAIN IN COMPLEX WITH ATPGS ; PMID:;
     Pdb:4YBK C-HELIX-OUT DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE ; PMID:;
     Pdb:4AGW DISCOVERY OF A SMALL MOLECULE TYPE II INHIBITOR OF WILD- TYP; PMID:;
     Pdb:3UQF C-SRC KINASE DOMAIN IN COMPLEX WITH BKI RM-1-89 ; PMID:;
     Pdb:3EN7 TARGETED POLYPHARMACOLOGY: CRYSTAL STRUCTURE OF THE C-SRC KI; PMID:;
     Pdb:4O2P KINASE DOMAIN OF CSRC IN COMPLEX WITH A SUBSTITUTED PYRAZOLO; PMID:;
     Pdb:3EL7 CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDIN; PMID:;
     Pdb:3EL8 CRYSTAL STRUCTURE OF C-SRC IN COMPLEX WITH PYRAZOLOPYRIMIDIN; PMID:;
     Pdb:3G6G EQUALLY POTENT INHIBITION OF C-SRC AND ABL BY COMPOUNDS THAT; PMID:;
     Pdb:5J5S SRC KINASE IN COMPLEX WITH A SULFONAMIDE INHIBITOR ; PMID:;
     Pdb:4DGG C-SRC KINASE DOMAIN IN COMPLEX WITH RM-1-176 ; PMID:;
     Pdb:4FIC KINASE DOMAIN OF CSRC IN COMPLEX WITH A HINGE REGION-BINDING; PMID:;
     Pdb:4YBJ TYPE II DASATINIB ANALOG CRYSTALLIZED WITH C-SRC KINASE ; PMID:;
30.          235          537          61          56.03          1.0e-105
     Pdb:3D7U STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIV; PMID:;
31.          238          537          61          55.47          1.0e-105
     Pdb:3U4W SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC4B; PMID:;
     Pdb:3U51 SRC IN COMPLEX WITH DNA-TEMPLATED MACROCYCLIC INHIBITOR MC1 ; PMID:;
32.          235          537          60          56.03          1.0e-105
     Pdb:1YOM CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH PURVA; PMID:;
     Pdb:1YOJ CRYSTAL STRUCTURE OF SRC KINASE DOMAIN ; PMID:;
33.          235          537          60          56.03          1.0e-105
     Pdb:2HWO CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVAL; PMID:;
     Pdb:3G5D KINASE DOMAIN OF CSRC IN COMPLEX WITH DASATINIB ; PMID:;
     Pdb:2QLQ CRYSTAL STRUCTURE OF SRC KINASE DOMAIN WITH COVALENT INHIBIT; PMID:;
     Pdb:3F3T KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL38 (TYPE I; PMID:;
     Pdb:3F3V KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL45 (TYPE I; PMID:;
     Pdb:3TZ7 KINASE DOMAIN OF CSRC IN COMPLEX WITH RL103 ; PMID:;
     Pdb:3TZ9 KINASE DOMAIN OF CSRC IN COMPLEX WITH RL130 ; PMID:;
     Pdb:3F3U KINASE DOMAIN OF CSRC IN COMPLEX WITH INHIBITOR RL37 (TYPE I; PMID:;
     Pdb:3TZ8 KINASE DOMAIN OF CSRC IN COMPLEX WITH RL104 ; PMID:;
     Pdb:2HWP CRYSTAL STRUCTURE OF SRC KINASE DOMAIN IN COMPLEX WITH COVAL; PMID:;
34.          235          537          60          56.03          1.0e-105
     Pdb:3DQW C-SRC KINASE DOMAIN THR338ILE MUTANT IN COMPLEX WITH ATPGS ; PMID:;
     Pdb:3G6H SRC THR338ILE INHIBITED IN THE DFG-ASP-OUT CONFORMATION ; PMID:;
35.          235          537          60          56.03          1.0e-105
     Pdb:3GEQ STRUCTURAL BASIS FOR THE CHEMICAL RESCUE OF SRC KINASE ACTIV; PMID:;
36.          235          537          60          56.03          1.0e-105
     Pdb:3QLF CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE ; PMID:;
     Pdb:3QLG CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE C-SRC TYROSINE ; PMID:;
     Pdb:3OEZ CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC T; PMID:;
     Pdb:3OF0 CRYSTAL STRUCTURE OF THE L317I MUTANT OF THE CHICKEN C-SRC T; PMID:;
37.          235          537          60          56.03          1.0e-105
     Pdb:3SVV CRYSTAL STRUCTURE OF T338C C-SRC COVALENTLY BOUND TO VINYLSU; PMID:;
38.          235          537          60          56.03          1.0e-105
     Pdb:4MCV STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE ; PMID:;
39.          235          537          60          56.03          1.0e-105
     Pdb:4MXX HUMAN SRC A403T MUTANT BOUND TO KINASE INHIBITOR BOSUTINIB ; PMID:;
40.          235          537          60          56.03          1.0e-105
     Pdb:4MXZ SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSU; PMID:;
     Pdb:4MXY SRC M314L T338M DOUBLE MUTANT BOUND TO KINASE INHIBITOR BOSU; PMID:;
41.          235          537          60          56.03          1.0e-104
     Pdb:5D11 KINASE DOMAIN OF CSRC IN COMPLEX WITH RL235 ; PMID:;
     Pdb:5D12 KINASE DOMAIN OF CSRC IN COMPLEX WITH RL40 ; PMID:;
     Pdb:2QQ7 CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN WITH I; PMID:;
     Pdb:3LOK DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH COVALENT I; PMID:;
     Pdb:3F3W DRUG RESISTANT CSRC KINASE DOMAIN IN COMPLEX WITH INHIBITOR ; PMID:;
     Pdb:5D10 KINASE DOMAIN OF CSRC IN COMPLEX WITH RL236 ; PMID:;
     Pdb:2QI8 CRYSTAL STRUCTURE OF DRUG RESISTANT SRC KINASE DOMAIN ; PMID:;
42.          235          537          60          56.03          1.0e-104
     Pdb:4LGH CRYSTAL STRUCTURE OF 1NM-PP1 BOUND TO ANALOG-SENSITIVE SRC K; PMID:;
43.          242          537          60          54.73          1.0e-101
     Pdb:4LGG STRUCTURE OF 3MB-PP1 BOUND TO ANALOG-SENSITIVE SRC KINASE ; PMID:;
44.          53          226          100          32.10          2.0e-99
     Pdb:1LCK SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COM; PMID:7512222;
45.          53          226          100          32.10          3.0e-99
     Pdb:4D8K CRYSTAL STRUCTURE OF A SH3-SH2 DOMAINS OF A LYMPHOCYTE-SPECI; PMID:;
46.          64          528          41          86.09          5.0e-95
     Pdb:1OPK STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE K; PMID:12654251,12654250;
47.          64          528          41          86.09          8.0e-95
     Pdb:2FO0 ORGANIZATION OF THE SH3-SH2 UNIT IN ACTIVE AND INACTIVE FORM; PMID:;
48.          64          528          41          86.09          1.0e-94
     Pdb:1OPL STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE K; PMID:12654251,12654250;
49.          64          226          100          30.06          1.0e-92
     Pdb:1X27 CRYSTAL STRUCTURE OF LCK SH2-SH3 WITH SH2 BINDING SITE OF P1; PMID:16245368;
50.          66          526          36          85.34          6.0e-85
     Pdb:4XI2 CRYSTAL STRUCTURE OF AN AUTO-INHIBITED FORM OF BRUTON'S TRYR; PMID:;
51.          116          528          42          76.44          8.0e-85
     Pdb:4XEY CRYSTAL STRUCTURE OF AN SH2-KINASE DOMAIN CONSTRUCT OF C-ABL; PMID:;
52.          236          533          52          55.10          9.0e-84
     Pdb:4UEU TYROSINE KINASE AS - A COMMON ANCESTOR OF SRC AND ABL ; PMID:;
     Pdb:4CSV TYROSINE KINASE AS - A COMMON ANCESTOR OF SRC AND ABL BOUND ; PMID:;
53.          67          529          37          85.71          4.0e-77
     Pdb:1K9A CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH CARBOXYL-TERMINAL ; PMID:11884384;
54.          236          528          44          54.17          5.0e-68
     Pdb:4XLI CRYSTAL STRUCTURE OF ABL2/ARG KINASE IN COMPLEX WITH DASATIN; PMID:;
55.          236          528          44          54.17          9.0e-68
     Pdb:3GVU THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH GLEEVEC ; PMID:;
     Pdb:3HMI THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH 5-AMINO-; PMID:;
     Pdb:2XYN HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680 ; PMID:;
56.          62          240          64          33.02          7.0e-67
     Pdb:3NHN CRYSTAL STRUCTURE OF THE SRC-FAMILY KINASE HCK SH3-SH2-LINKE; PMID:;
57.          236          528          43          54.17          9.0e-67
     Pdb:3DK6 CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WIT; PMID:;
58.          236          528          43          54.17          2.0e-66
     Pdb:1IEP CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH; PMID:12154025;
     Pdb:2HZN ABL KINASE DOMAIN IN COMPLEX WITH NVP-AFG210 ; PMID:;
     Pdb:1OPJ STRUCTURAL BASIS FOR THE AUTO-INHIBITION OF C-ABL TYROSINE K; PMID:12654251,12654250;
     Pdb:3MS9 ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) I; PMID:;
     Pdb:3K5V STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2 ; PMID:;
     Pdb:3MSS ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN ; PMID:;
     Pdb:1FPU CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMA; PMID:10988075;
     Pdb:1M52 CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH; PMID:12154025;
59.          236          528          43          54.17          3.0e-66
     Pdb:2QOH CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A ; PMID:;
     Pdb:3KF4 STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIB; PMID:;
     Pdb:3KFA STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIB; PMID:;
60.          236          528          43          54.17          3.0e-66
     Pdb:3OXZ CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT ; PMID:;
61.          236          528          43          54.17          3.0e-66
     Pdb:4WA9 THE CRYSTAL STRUCTURE OF HUMAN ABL1 WILD TYPE KINASE DOMAIN ; PMID:;
62.          236          528          43          54.17          4.0e-66
     Pdb:2G1T A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE ; PMID:;
     Pdb:4YC8 C-HELIX-OUT BINDING OF DASATINIB ANALOG TO C-ABL KINASE ; PMID:;
     Pdb:3UE4 STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITO; PMID:;
63.          236          528          43          54.17          4.0e-66
     Pdb:2E2B CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH; PMID:;
64.          236          528          43          54.17          5.0e-66
     Pdb:2HIW CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALY; PMID:;
65.          236          528          43          54.17          5.0e-66
     Pdb:2HYY HUMAN ABL KINASE DOMAIN IN COMPLEX WITH IMATINIB (STI571, GL; PMID:;
     Pdb:2HZ4 ABL KINASE DOMAIN UNLIGATED AND IN COMPLEX WITH TETRAHYDROST; PMID:;
66.          236          528          43          54.17          5.0e-66
     Pdb:3PYY DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, SMALL-MO; PMID:;
67.          236          528          43          54.17          6.0e-66
     Pdb:2GQG X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO A; PMID:;
68.          236          528          43          54.17          6.0e-66
     Pdb:2HZI ABL KINASE DOMAIN IN COMPLEX WITH PD180970 ; PMID:;
     Pdb:3CS9 HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB ; PMID:;
69.          236          528          43          54.17          6.0e-66
     Pdb:3DK3 CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WIT; PMID:;
70.          236          528          43          54.17          6.0e-66
     Pdb:3QRI THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX; PMID:;
     Pdb:3QRK THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX; PMID:;
71.          236          528          43          54.17          7.0e-66
     Pdb:2HZ0 ABL KINASE DOMAIN IN COMPLEX WITH NVP-AEG082 ; PMID:;
72.          236          528          43          54.17          1.0e-65
     Pdb:2F4J STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL ; PMID:;
73.          236          528          43          54.17          1.0e-65
     Pdb:2G2H A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE ; PMID:;
     Pdb:2G2F A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE ; PMID:;
     Pdb:2G2I A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE ; PMID:;
74.          236          528          43          54.17          1.0e-65
     Pdb:2Z60 CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WI; PMID:;
     Pdb:3IK3 AP24534, A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMI; PMID:;
75.          236          528          43          54.17          1.0e-65
     Pdb:3DK7 CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WIT; PMID:;
76.          236          528          43          54.17          1.0e-65
     Pdb:3OY3 CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WI; PMID:;
77.          236          528          43          54.17          2.0e-65
     Pdb:2V7A CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH TH; PMID:;
78.          236          528          43          54.17          2.0e-65
     Pdb:4TWP THE CRYSTAL STRUCTURE OF HUMAN ABL1 T315I GATEKEEPER MUTANT ; PMID:;
79.          236          528          43          54.17          3.0e-65
     Pdb:3QRJ THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTA; PMID:;
80.          239          525          41          53.06          1.0e-61
     Pdb:3SXS CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLE; PMID:;
     Pdb:3SXR CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLE; PMID:;
81.          62          224          65          30.06          1.0e-60
     Pdb:4U5W CRYSTAL STRUCTURE OF HIV-1 NEF-SF2 CORE DOMAIN IN COMPLEX WI; PMID:;
82.          245          520          40          51.02          1.0e-59
     Pdb:3QGY CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX ; PMID:;
     Pdb:3QGW CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR ; PMID:;
83.          237          520          38          52.50          2.0e-59
     Pdb:3T9T CRYSTAL STRUCTURE OF BTK MUTANT (F435T,K596R) COMPLEXED WITH; PMID:;
84.          245          520          39          51.02          8.0e-59
     Pdb:3MJ1 X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR RO51; PMID:;
     Pdb:4MF1 ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR 12; PMID:;
     Pdb:4RFM ITK KINASE DOMAIN IN COMPLEX WITH COMPOUND 1 N-{1-[(1,1-DIOX; PMID:;
     Pdb:3MIY X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH SUNITINIB ; PMID:;
     Pdb:3MJ2 X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BMS-; PMID:;
     Pdb:4PQN ITK KINASE DOMAIN WITH COMPOUND GNE-9822 ; PMID:;
85.          237          520          38          52.50          9.0e-59
     Pdb:4HCU CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40 ; PMID:;
     Pdb:4M0Y CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 1 [4- (CAR; PMID:;
     Pdb:4M13 CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 8 [4- (CAR; PMID:;
     Pdb:4M0Z CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 5 {4- (CAR; PMID:;
     Pdb:4M15 CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4- (CAR; PMID:;
     Pdb:4HCV CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53 ; PMID:;
     Pdb:4M12 CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 7 [4- (CAR; PMID:;
     Pdb:4M14 CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 9 [4- (CAR; PMID:;
     Pdb:4HCT CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52 ; PMID:;
86.          119          226          100          19.85          1.0e-58
     Pdb:1BHF P56LCK SH2 DOMAIN INHIBITOR COMPLEX ; PMID:9685372;
     Pdb:1BHH FREE P56LCK SH2 DOMAIN ; PMID:9685372;
87.          119          226          100          19.85          1.0e-58
     Pdb:1LCJ SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE; PMID:7680435;
88.          245          520          39          51.02          2.0e-58
     Pdb:1SNX CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATAL; PMID:;
     Pdb:1SNU CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYRO; PMID:;
     Pdb:1SM2 CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSI; PMID:;
89.          245          520          39          51.02          2.0e-58
     Pdb:3V5J CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE I; PMID:;
     Pdb:3V8W CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE I; PMID:;
     Pdb:3V5L CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE I; PMID:;
     Pdb:3V8T CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASE I; PMID:;
90.          238          526          38          53.43          2.0e-58
     Pdb:3OCT CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R I; PMID:;
91.          238          526          38          53.43          3.0e-58
     Pdb:5BQ0 CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINA; PMID:;
     Pdb:3GEN THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINAS; PMID:;
92.          238          526          38          53.43          3.0e-58
     Pdb:3OCS CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WIT; PMID:;
93.          238          526          38          53.43          3.0e-58
     Pdb:3P08 CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN ; PMID:;
94.          238          526          38          53.43          3.0e-58
     Pdb:4OTF CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON'S TYROSINE ; PMID:;
95.          238          526          38          53.43          3.0e-58
     Pdb:4Y95 CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF BRUTON'S TYROSINE ; PMID:;
96.          238          526          38          53.43          4.0e-58
     Pdb:3PIZ CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMI; PMID:;
     Pdb:3PJ1 CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(2,6; PMID:;
     Pdb:3PIX CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOP; PMID:;
     Pdb:3PIY CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406 ; PMID:;
     Pdb:3PJ2 CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(; PMID:;
     Pdb:3PJ3 CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METH; PMID:;
97.          238          526          38          53.43          5.0e-58
     Pdb:4Y93 CRYSTAL STRUCTURE OF THE PH-TH-KINASE CONSTRUCT OF BRUTON'S ; PMID:;
98.          238          526          38          53.43          2.0e-57
     Pdb:4OTR CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6-CYCL; PMID:;
     Pdb:4OT6 CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 4- MET; PMID:;
     Pdb:4RFY CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6- (DI; PMID:;
     Pdb:4RFZ CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 6- (DI; PMID:;
     Pdb:4RG0 CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[8-F; PMID:;
     Pdb:4OT5 CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 4-TERT; PMID:;
     Pdb:4OTQ CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 1-[5-[; PMID:;
99.          245          520          38          51.02          2.0e-57
     Pdb:4KIO KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH A COVALENT; PMID:;
     Pdb:4L7S KINASE DOMAIN MUTANT OF HUMAN ITK IN COMPLEX WITH AN AMINOBE; PMID:;
     Pdb:4QD6 ITK KINASE DOMAIN IN COMPLEX WITH INHIBITOR COMPOUND ; PMID:;
     Pdb:4PP9 ITK KINASE DOMAIN WITH COMPOUND 1 (N-[1-(3-CYANOBENZYL)-1H-P; PMID:;
     Pdb:4MF0 ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR CO; PMID:;
     Pdb:4PPA ITK KINASE DOMAIN WITH COMPOUND 11 (N-[1-(3-CYANOBENZYL)-1H-; PMID:;
     Pdb:4PPC ITK KINASE DOMAIN WITH COMPOUND 27 (N-{1-[(1R)-3-(DIMETHYLAM; PMID:;
     Pdb:4PPB ITK KINASE DOMAIN WITH COMPOUND 28 (N-{1-[(1S)-3-(DIMETHYLAM; PMID:;
100.          238          526          38          53.43          4.0e-57
     Pdb:3K54 STRUCTURES OF HUMAN BRUTON'S TYROSINE KINASE IN ACTIVE AND I; PMID:;
101.          239          526          38          53.25          4.0e-57
     Pdb:4NWM CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINA; PMID:;
102.          122          226          100          19.29          8.0e-57
     Pdb:1LKK HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE; PMID:;
103.          245          526          38          52.13          9.0e-57
     Pdb:1K2P CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE DOMAIN ; PMID:11527964;
104.          123          226          100          19.11          2.0e-56
     Pdb:1LKL HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE; PMID:;
105.          124          226          100          18.92          9.0e-56
     Pdb:1BHH FREE P56LCK SH2 DOMAIN ; PMID:9685372;
106.          123          226          99          19.11          9.0e-56
     Pdb:1FBZ STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE, NON; PMID:;
107.          124          226          99          18.92          3.0e-55
     Pdb:1IJR CRYSTAL STRUCTURE OF LCK SH2 COMPLEXED WITH NONPEPTIDE PHOSP; PMID:11527723;
108.          230          529          38          55.47          3.0e-53
     Pdb:1BYG KINASE DOMAIN OF HUMAN C-TERMINAL SRC KINASE (CSK) IN COMPLE; PMID:9878439;
109.          238          529          39          53.99          4.0e-53
     Pdb:3D7T STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIV; PMID:;
110.          127          222          100          17.63          1.0e-52
     Pdb:1CWD HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHONOPEPTIDE; PMID:7532720;
     Pdb:1CWE HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE ; PMID:7532720;
111.          238          529          39          53.99          1.0e-52
     Pdb:3D7U STRUCTURAL BASIS FOR THE RECOGNITION OF C-SRC BY ITS INACTIV; PMID:;
112.          223          528          38          56.59          1.0e-52
     Pdb:2QOK HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:S76; PMID:;
113.          223          528          38          56.59          1.0e-52
     Pdb:2R2P KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5) ; PMID:;
114.          223          525          38          56.03          2.0e-52
     Pdb:1JPA CRYSTAL STRUCTURE OF UNPHOSPHORYLATED EPHB2 RECEPTOR TYROSIN; PMID:11572780;
115.          226          525          38          55.47          2.0e-52
     Pdb:3ZFM CRYSTAL STRUCTURE OF EPHB2 ; PMID:;
116.          223          528          37          56.59          2.0e-52
     Pdb:2QO2 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATE; PMID:;
     Pdb:2QO7 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, DEPHOSPHORYLATE; PMID:;
     Pdb:2QO9 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, PHOSPHORYLATED,; PMID:;
     Pdb:2QOQ HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, BASE, AMP-PNP B; PMID:;
     Pdb:2GSF THE HUMAN EPHA3 RECEPTOR TYROSINE KINASE AND JUXTAMEMBRANE R; PMID:;
117.          223          528          37          56.59          2.0e-52
     Pdb:2QOF HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F MUTANT ; PMID:;
118.          223          528          37          56.59          2.0e-52
     Pdb:3FY2 HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRA; PMID:;
     Pdb:3FXX HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION BOUND TO SUBSTRA; PMID:;
119.          239          528          39          53.62          3.0e-52
     Pdb:2QOB HUMAN EPHA3 KINASE DOMAIN, BASE STRUCTURE ; PMID:;
     Pdb:2QOC HUMAN EPHA3 KINASE DOMAIN, PHOSPHORYLATED, AMP-PNP BOUND STR; PMID:;
120.          239          528          39          53.62          3.0e-52
     Pdb:3DZQ HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH INHIBITOR AWL-II- ; PMID:;
     Pdb:4GK4 HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 90 ; PMID:;
     Pdb:4P5Q HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVA; PMID:;
     Pdb:4G2F HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 7 ; PMID:;
     Pdb:4GK3 HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 87 ; PMID:;
     Pdb:4P5Z HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVA; PMID:;
     Pdb:4P4C HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH QUINOXALINE DERIVA; PMID:;
     Pdb:4TWO HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH COMPOUND 164 ; PMID:;
     Pdb:4GK2 HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH LIGAND 66 ; PMID:;
     Pdb:4TWN HUMAN EPHA3 KINASE DOMAIN IN COMPLEX WITH BIRB796 ; PMID:;
121.          223          528          37          56.59          3.0e-52
     Pdb:2QOL HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596:Y602:S768G; PMID:;
122.          223          528          37          56.59          3.0e-52
     Pdb:2QOD HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y602F MUTANT ; PMID:;
123.          223          528          37          56.59          3.0e-52
     Pdb:2QOI HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F DOU; PMID:;
124.          239          528          39          53.62          6.0e-52
     Pdb:2XYU CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH VUF; PMID:;
125.          239          528          39          53.62          7.0e-52
     Pdb:2Y6O CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DAS; PMID:;
     Pdb:2Y6M CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN ; PMID:;
126.          223          528          37          56.59          7.0e-52
     Pdb:2QOO HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y74; PMID:;
127.          251          530          39          51.76          1.0e-51
     Pdb:1MQB CRYSTAL STRUCTURE OF EPHRIN A2 (EPHA2) RECEPTOR PROTEIN KINA; PMID:12467573;
128.          122          527          33          75.14          1.0e-51
     Pdb:3CBL CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOM; PMID:;
     Pdb:4E93 CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOM; PMID:;
     Pdb:3BKB CRYSTAL STRUCTURE OF HUMAN FELINE SARCOMA VIRAL ONCOGENE HOM; PMID:;
     Pdb:3CD3 CRYSTAL STRUCTURE OF PHOSPHORYLATED HUMAN FELINE SARCOMA VIR; PMID:;
129.          226          525          38          55.47          2.0e-51
     Pdb:3ZFX CRYSTAL STRUCTURE OF EPHB1 ; PMID:;
130.          239          528          38          53.62          2.0e-51
     Pdb:2HEN CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COM; PMID:;
131.          223          528          37          56.59          2.0e-51
     Pdb:2QON HUMAN EPHA3 KINASE AND JUXTAMEMBRANE REGION, Y596F:Y602F:Y74; PMID:;
132.          251          528          39          51.39          3.0e-51
     Pdb:4P2K STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2 ; PMID:;
     Pdb:4PDO STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2 ; PMID:;
     Pdb:4TRL STRUCTURE OF EPHRIN TYPE-A RECEPTOR 2 ; PMID:;
133.          223          528          37          56.59          3.0e-51
     Pdb:2HEL CRYSTAL STRUCTURE OF A MUTANT EPHA4 KINASE DOMAIN (Y742A) ; PMID:;
134.          232          528          38          54.92          6.0e-51
     Pdb:4AW5 COMPLEX OF THE EPHB4 KINASE DOMAIN WITH AN OXINDOLE INHIBITO; PMID:;
135.          226          528          37          56.03          1.0e-50
136.          237          529          38          54.17          2.0e-50
     Pdb:4CKI CRYSTAL STRUCTURE OF ONCOGENIC RET TYROSINE KINASE M918T BOU; PMID:;
137.          226          528          38          56.03          3.0e-50
     Pdb:3ZFY CRYSTAL STRUCTURE OF EPHB3 ; PMID:;
138.          226          528          37          56.03          3.0e-50
     Pdb:2YN8 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX ; PMID:;
139.          237          529          38          54.17          6.0e-50
140.          237          529          38          54.17          7.0e-50
     Pdb:2X2L CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMA; PMID:;
     Pdb:4CKJ CRYSTAL STRUCTURE OF RET TYROSINE KINASE DOMAIN BOUND TO ADE; PMID:;
     Pdb:2IVT CRYSTAL STRUCTURE OF PHOSPHORYLATED RET TYROSINE KINASE DOMA; PMID:;
     Pdb:2IVS CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED RET TYROSINE KINASE ; PMID:;
141.          239          528          38          53.62          1.0e-49
     Pdb:2X9F EPHB4 KINASE DOMAIN INHIBITOR COMPLEX ; PMID:;
     Pdb:4BB4 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX ; PMID:;
     Pdb:2VWU EPHB4 KINASE DOMAIN INHIBITOR COMPLEX ; PMID:;
142.          223          525          37          56.03          1.0e-49
     Pdb:3DKO COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A REC; PMID:;
     Pdb:2REI KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) ; PMID:;
 
NR homologs                 
No.    Start    End    Identity%    Coverage%    Evalue
 

Notes: The reference system provides subject-oriented search and sequence-oriented search for reference collection. The reference filter supports the classification and selection of references. You can use a group of buttons to select references based on your interest or the relative level of references that are justified base on some criteria, e.g. trusted or high similairties. By deafult, PSCA shows the references whose levels are better than gathering or high similarity of reference classification.

Contact Webmaster JCSG Menu